News | March 15, 2012

MRI Shows Prolonged Space Travel Causes Brain, Eye Abnormalities in Astronauts

March 15, 2012 - Magnetic resonance imaging (MRI) of the eyes and brains of 27 astronauts who have spent prolonged periods of time in space revealed optical abnormalities similar to those that can occur in intracranial hypertension of unknown cause, a potentially serious condition in which pressure builds within the skull. A retrospective analysis of the MRI data appears online in the journal Radiology.

A team of researchers performed MRIs and analyzed the data on the 27 astronauts, each of whom were exposed to microgravity, or zero gravity, for an average of 108 days while on space shuttle missions and/or the International Space Station (ISS), a habitable research facility that has been orbiting the earth since 1998. Eight of the 27 astronauts underwent a second MRI exam after a second space mission that lasted an average of 39 days.

“The MRI findings revealed various combinations of abnormalities following both short- and long-term cumulative exposure to microgravity also seen with idiopathic intracranial hypertension,” said Larry A. Kramer, M.D., professor of diagnostic and interventional imaging at The University of Texas Medical School at Houston. “These changes that occur during exposure to microgravity may help scientists to better understand the mechanisms responsible for intracranial hypertension in non-space traveling patients.”

Among astronauts with more than 30 days of cumulative lifetime exposure to microgravity, findings included expansion of the cerebral spinal fluid space surrounding the optic nerve in nine of the 27 (33 percent) astronauts, flattening of the rear of the eyeball in six (22 percent), bulging of the optic nerve in four (15 percent) and changes in the pituitary gland and its connection to the brain in three (11 percent) of the astronauts. The pituitary gland secretes and stores hormones that regulate a variety of important body functions.

The same types of abnormalities are observed in cases of intracranial hypertension where no cause can be found for increased pressure around the brain. The pressure causes swelling of the juncture between the optic nerve and the eyeball, which can result in visual impairment.

Bone mineral loss and muscle atrophy are some of the known effects of zero gravity on astronauts. With the onset of longer excursions in space afforded by the ISS, visual changes have also been observed and are now being studied.

“Microgravity-induced intracranial hypertension represents a hypothetical risk factor and a potential limitation to long-duration space travel,” Kramer said.

William J. Tarver, M.D., M.P.H., chief of flight medicine clinic at NASA/Johnson Space Center, said the agency has noted changes in vision in some ISS astronauts, the origin of which is not yet fully understood. No astronauts have been considered ineligible for space flight duties as a result of the findings, which he said are suspicious but not conclusive of intracranial hypertension.

“NASA has placed this problem high on its list of human risks, has initiated a comprehensive program to study its mechanisms and implications, and will continue to closely monitor the situation,” Tarver said.

For more information: http://radiology.rsna.org

Related Content

Mayo Clinic Installing First FDA-Approved Clinical 7T MRI
News | Magnetic Resonance Imaging (MRI) | October 20, 2017
Mayo Clinic in Rochester, Minn., will have the first clinical 7-Tesla magnetic resonance imaging (MRI) scanner in North...
Contrast-Enhanced Ultrasound Safe and Effective Detector of Liver Cancer
News | Ultrasound Imaging | October 19, 2017
Doctors can effectively detect liver cancer with ultrasound and tiny microbubbles, according to a study announced at...
Study Examines Characteristics of Mobile Mammography Patients
News | Mammography | October 18, 2017
Significant differences were found among women receiving mammography at a cancer center versus those visiting a mobile...
Machine Learning Identifies Breast Lesions Likely to Become Cancer
News | Artificial Intelligence | October 18, 2017
A machine learning tool can help identify which high-risk breast lesions are likely to become cancerous, according to a...
Cleveland Clinic Researchers Reveal Biomarker for Guiding Prostate Cancer Treatment
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-r
TMIST Mammography Study Opens Enrollment
News | Mammography | October 16, 2017
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of...
FDA Clears Siemens Magnetom Terra 7T MRI Device

FDA Clears Siemens Magnetom Terra 7T MRI Device

Technology | Magnetic Resonance Imaging (MRI) | October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
CyberKnife System Provides Excellent Long-Term Control of Low-Risk Prostate Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent...
Overlay Init